Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of the Effects of Belatacept and Anticalcineurins on Endothelial Function in Renal Transplant Patients
NCT06291077Phase 4Recruiting
- Sponsor
- Rouen University Hospital
- Start
- Apr 2026
- Primary completion
- Feb 2029
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 4 trial of belatacept in Kidney disease, sponsored by Rouen University Hospital. Started Apr 2026; status: recruiting.
02
Drugs
belatacept
03
Conditions
Kidney disease
Beyond the preview
Go deeper on NCT06291077.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06291077.